Cargando…
P617: FIXED-DURATION (FD) IBRUTINIB + VENETOCLAX FOR FIRST-LINE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)/SMALL LYMPHOCYTIC LYMPHOMA (SLL): 4-Y FOLLOW-UP FROM FD COHORT OF PHASE 2 CAPTIVATE STUDY
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429610/ http://dx.doi.org/10.1097/01.HS9.0000969372.28228.42 |
| _version_ | 1785090757931040768 |
|---|---|
| author | Ghia, Paolo Allan, John Siddiqi, Tanya Wierda, William G. Tam, Constantine Moreno, Carol Tedeschi, Alessandra Szafer-Glusman, Edith Zhou, Cathy Abbazio, Chris Dean, Jim Szoke, Anita Barr, Paul M. |
| author_facet | Ghia, Paolo Allan, John Siddiqi, Tanya Wierda, William G. Tam, Constantine Moreno, Carol Tedeschi, Alessandra Szafer-Glusman, Edith Zhou, Cathy Abbazio, Chris Dean, Jim Szoke, Anita Barr, Paul M. |
| author_sort | Ghia, Paolo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429610 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104296102023-08-17 P617: FIXED-DURATION (FD) IBRUTINIB + VENETOCLAX FOR FIRST-LINE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)/SMALL LYMPHOCYTIC LYMPHOMA (SLL): 4-Y FOLLOW-UP FROM FD COHORT OF PHASE 2 CAPTIVATE STUDY Ghia, Paolo Allan, John Siddiqi, Tanya Wierda, William G. Tam, Constantine Moreno, Carol Tedeschi, Alessandra Szafer-Glusman, Edith Zhou, Cathy Abbazio, Chris Dean, Jim Szoke, Anita Barr, Paul M. Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429610/ http://dx.doi.org/10.1097/01.HS9.0000969372.28228.42 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Ghia, Paolo Allan, John Siddiqi, Tanya Wierda, William G. Tam, Constantine Moreno, Carol Tedeschi, Alessandra Szafer-Glusman, Edith Zhou, Cathy Abbazio, Chris Dean, Jim Szoke, Anita Barr, Paul M. P617: FIXED-DURATION (FD) IBRUTINIB + VENETOCLAX FOR FIRST-LINE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)/SMALL LYMPHOCYTIC LYMPHOMA (SLL): 4-Y FOLLOW-UP FROM FD COHORT OF PHASE 2 CAPTIVATE STUDY |
| title | P617: FIXED-DURATION (FD) IBRUTINIB + VENETOCLAX FOR FIRST-LINE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)/SMALL LYMPHOCYTIC LYMPHOMA (SLL): 4-Y FOLLOW-UP FROM FD COHORT OF PHASE 2 CAPTIVATE STUDY |
| title_full | P617: FIXED-DURATION (FD) IBRUTINIB + VENETOCLAX FOR FIRST-LINE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)/SMALL LYMPHOCYTIC LYMPHOMA (SLL): 4-Y FOLLOW-UP FROM FD COHORT OF PHASE 2 CAPTIVATE STUDY |
| title_fullStr | P617: FIXED-DURATION (FD) IBRUTINIB + VENETOCLAX FOR FIRST-LINE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)/SMALL LYMPHOCYTIC LYMPHOMA (SLL): 4-Y FOLLOW-UP FROM FD COHORT OF PHASE 2 CAPTIVATE STUDY |
| title_full_unstemmed | P617: FIXED-DURATION (FD) IBRUTINIB + VENETOCLAX FOR FIRST-LINE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)/SMALL LYMPHOCYTIC LYMPHOMA (SLL): 4-Y FOLLOW-UP FROM FD COHORT OF PHASE 2 CAPTIVATE STUDY |
| title_short | P617: FIXED-DURATION (FD) IBRUTINIB + VENETOCLAX FOR FIRST-LINE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)/SMALL LYMPHOCYTIC LYMPHOMA (SLL): 4-Y FOLLOW-UP FROM FD COHORT OF PHASE 2 CAPTIVATE STUDY |
| title_sort | p617: fixed-duration (fd) ibrutinib + venetoclax for first-line treatment of chronic lymphocytic leukemia (cll)/small lymphocytic lymphoma (sll): 4-y follow-up from fd cohort of phase 2 captivate study |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429610/ http://dx.doi.org/10.1097/01.HS9.0000969372.28228.42 |
| work_keys_str_mv | AT ghiapaolo p617fixeddurationfdibrutinibvenetoclaxforfirstlinetreatmentofchroniclymphocyticleukemiacllsmalllymphocyticlymphomasll4yfollowupfromfdcohortofphase2captivatestudy AT allanjohn p617fixeddurationfdibrutinibvenetoclaxforfirstlinetreatmentofchroniclymphocyticleukemiacllsmalllymphocyticlymphomasll4yfollowupfromfdcohortofphase2captivatestudy AT siddiqitanya p617fixeddurationfdibrutinibvenetoclaxforfirstlinetreatmentofchroniclymphocyticleukemiacllsmalllymphocyticlymphomasll4yfollowupfromfdcohortofphase2captivatestudy AT wierdawilliamg p617fixeddurationfdibrutinibvenetoclaxforfirstlinetreatmentofchroniclymphocyticleukemiacllsmalllymphocyticlymphomasll4yfollowupfromfdcohortofphase2captivatestudy AT tamconstantine p617fixeddurationfdibrutinibvenetoclaxforfirstlinetreatmentofchroniclymphocyticleukemiacllsmalllymphocyticlymphomasll4yfollowupfromfdcohortofphase2captivatestudy AT morenocarol p617fixeddurationfdibrutinibvenetoclaxforfirstlinetreatmentofchroniclymphocyticleukemiacllsmalllymphocyticlymphomasll4yfollowupfromfdcohortofphase2captivatestudy AT tedeschialessandra p617fixeddurationfdibrutinibvenetoclaxforfirstlinetreatmentofchroniclymphocyticleukemiacllsmalllymphocyticlymphomasll4yfollowupfromfdcohortofphase2captivatestudy AT szaferglusmanedith p617fixeddurationfdibrutinibvenetoclaxforfirstlinetreatmentofchroniclymphocyticleukemiacllsmalllymphocyticlymphomasll4yfollowupfromfdcohortofphase2captivatestudy AT zhoucathy p617fixeddurationfdibrutinibvenetoclaxforfirstlinetreatmentofchroniclymphocyticleukemiacllsmalllymphocyticlymphomasll4yfollowupfromfdcohortofphase2captivatestudy AT abbaziochris p617fixeddurationfdibrutinibvenetoclaxforfirstlinetreatmentofchroniclymphocyticleukemiacllsmalllymphocyticlymphomasll4yfollowupfromfdcohortofphase2captivatestudy AT deanjim p617fixeddurationfdibrutinibvenetoclaxforfirstlinetreatmentofchroniclymphocyticleukemiacllsmalllymphocyticlymphomasll4yfollowupfromfdcohortofphase2captivatestudy AT szokeanita p617fixeddurationfdibrutinibvenetoclaxforfirstlinetreatmentofchroniclymphocyticleukemiacllsmalllymphocyticlymphomasll4yfollowupfromfdcohortofphase2captivatestudy AT barrpaulm p617fixeddurationfdibrutinibvenetoclaxforfirstlinetreatmentofchroniclymphocyticleukemiacllsmalllymphocyticlymphomasll4yfollowupfromfdcohortofphase2captivatestudy |